Literature DB >> 30358242

Trajectories in Cerebral Blood Flow Following Antidepressant Treatment in Late-Life Depression: Support for the Vascular Depression Hypothesis.

Wenjing Wei1,2, Helmet T Karim3, Chemin Lin4,5, Akiko Mizuno3, Carmen Andreescu3, Jordan F Karp3, Charles F Reynolds3, Howard J Aizenstein6,3,7.   

Abstract

OBJECTIVE: Studies have identified longitudinally that there exists an association between depression, cerebral blood flow (CBF), and white matter hyperintensities that are thought to be due to vascular pathologies in the brain. However, the changes in CBF, a measure that reflects cerebrovascular integrity, following pharmacotherapy are not well understood. In this study, we investigated the dynamic CBF changes over the course of antidepressant treatment and the association of these changes with depressive symptoms.
METHODS: We used pseudocontinuous arterial spin labeling to investigate CBF changes in a sample of older patients (≥ 50 years of age; N = 46; 29 female) with a DSM-IV diagnosis of major depressive disorder. Participants had 5 magnetic resonance imaging scans (at baseline, the day after receiving a placebo, the day after receiving a first dose of venlafaxine, a week after starting venlafaxine treatment, and at the end of trial [12 weeks]). Montgomery-Asberg Depression Rating Scale (MADRS) was used to evaluate depression severity and treatment outcome. We investigated the association between changes in depression severity with changes in voxel-wise CBF while adjusting for potential confounding factors.
RESULTS: Increased CBF in the middle and posterior cingulate between baseline and end of treatment was significantly associated with percent decrease in MADRS score, independent of sex and Mini-Mental State Examination score (5,000 permutations, cluster forming threshold P < .005, family-wise error P < .05). No significant effects were detected between baseline and other scans (ie, placebo, acute [single dose], or subacute [after a week]).
CONCLUSIONS: Regional CBF increases were associated with decreases in depressive symptoms. This observation is consistent with the vascular depression hypothesis in late-life depression. TRIAL REGISTRATION: ClinicalTrials.gov identifiers: NCT00892047 and NCT01124188. © Copyright 2018 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30358242      PMCID: PMC6419103          DOI: 10.4088/JCP.18m12106

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  82 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial.

Authors:  Eric J Lenze; Benoit H Mulsant; Daniel M Blumberger; Jordan F Karp; John W Newcomer; Stewart J Anderson; Mary Amanda Dew; Meryl A Butters; Jacqueline A Stack; Amy E Begley; Charles F Reynolds
Journal:  Lancet       Date:  2015-09-27       Impact factor: 79.321

3.  Single-dose serotonergic stimulation shows widespread effects on functional brain connectivity.

Authors:  Bernadet L Klaassens; Helene C van Gorsel; Najmeh Khalili-Mahani; Jeroen van der Grond; Bradley T Wyman; Brandon Whitcher; Serge A R B Rombouts; Joop M A van Gerven
Journal:  Neuroimage       Date:  2015-08-12       Impact factor: 6.556

4.  Magnetic resonance imaging predictors of treatment response in late-life depression.

Authors:  Howard J Aizenstein; Alexander Khalaf; Sarah E Walker; Carmen Andreescu
Journal:  J Geriatr Psychiatry Neurol       Date:  2013-12-30       Impact factor: 2.680

Review 5.  Late-life depression: evidence-based treatment and promising new directions for research and clinical practice.

Authors:  Carmen Andreescu; Charles F Reynolds
Journal:  Psychiatr Clin North Am       Date:  2011-06

6.  Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies.

Authors:  Cynthia H Y Fu; Herbert Steiner; Sergi G Costafreda
Journal:  Neurobiol Dis       Date:  2012-06-01       Impact factor: 5.996

7.  Altered cerebral vasoregulation in hypertension and stroke.

Authors:  V Novak; A Chowdhary; B Farrar; H Nagaraja; J Braun; R Kanard; P Novak; A Slivka
Journal:  Neurology       Date:  2003-05-27       Impact factor: 9.910

8.  Changes in regional cerebral blood flow following antidepressant treatment in late-life depression.

Authors:  Junko Ishizaki; Hideki Yamamoto; Taro Takahashi; Maki Takeda; Madoka Yano; Masaru Mimura
Journal:  Int J Geriatr Psychiatry       Date:  2008-08       Impact factor: 3.485

9.  Psychotic symptoms in major depressive disorder are associated with reduced regional cerebral blood flow in the subgenual anterior cingulate cortex: a voxel-based single photon emission computed tomography (SPECT) study.

Authors:  Cesar R Skaf; Airton Yamada; Griselda E J Garrido; Carlos A Buchpiguel; Sergio Akamine; Claudio C Castro; Geraldo F Busatto
Journal:  J Affect Disord       Date:  2002-04       Impact factor: 4.839

10.  Structural brain changes as biomarkers and outcome predictors in patients with late-life depression: a cross-sectional and prospective study.

Authors:  Salma R I Ribeiz; Fabio Duran; Melaine C Oliveira; Diana Bezerra; Claudio Campi Castro; David C Steffens; Geraldo Busatto Filho; Cássio M C Bottino
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

View more
  4 in total

Review 1.  The enigma of vascular depression in old age: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2022-06-15       Impact factor: 3.850

Review 2.  Pathomechanisms of Vascular Depression in Older Adults.

Authors:  Kurt A Jellinger
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

Review 3.  Perspectives on the complex links between depression and dementia.

Authors:  Antoine Hakim
Journal:  Front Aging Neurosci       Date:  2022-08-24       Impact factor: 5.702

4.  Single and repeated ketamine treatment induces perfusion changes in sensory and limbic networks in major depressive disorder.

Authors:  Ashish K Sahib; Joana R A Loureiro; Megha M Vasavada; Antoni Kubicki; Shantanu H Joshi; Kai Wang; Roger P Woods; Eliza Congdon; Danny J J Wang; Michael L Boucher; Randall Espinoza; Katherine L Narr
Journal:  Eur Neuropsychopharmacol       Date:  2020-02-12       Impact factor: 5.415

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.